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Dietary normalization from a fat, fructose
and cholesterol-rich diet to chow limits the
amount of myocardial collagen in a
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Berit Østergaard Christoffersen2, Henrik Duelund Pedersen1,4 and Lisbeth Høier Olsen1*
Abstract
Background: Dietary interventions have been shown to attenuate some of the myocardial pathological alterations
associated with obesity. This study evaluated the effect of dietary normalization from a fat/fructose/cholesterol-rich diet
to chow on left ventricular (LV) myocardial fibrosis, fat infiltration and hypertrophy but also the specific influence of
obesity, plasma lipids and glucose metabolism markers on heart morphology in a Göttingen Minipig model of obesity.
Methods: Forty castrated male Göttingen Minipigs were assigned to three groups fed either standard minipig
chow (SD, n = 8) for 13 months, fat/fructose/cholesterol-rich diet (FFC, n = 16) for 13 months or fat/fructose/
cholesterol-rich diet for 7 months and then changed to standard minipig chow for the remaining 6 months
(FFC/SD, n = 16). Body weight, body fat percentage, plasma lipids and glucose metabolism markers were
evaluated in all three groups after 6–7 months (prior to diet adjustment for FFC/SD) and again before
termination. Further, biochemical quantification of myocardial collagen and triglyceride content, semi-
quantitative histological evaluation of fibrosis and fat infiltration and quantitative histological analysis of
collagen and cardiomyocyte diameter were performed and heart weight was obtained after termination.
Group differences were evaluated using Kruskal-Wallis test and Fisher’s exact test for categorical variables.
Pearson correlation analysis was performed to test for correlations between myocardial changes and selected
explanatory variables. For non-parametric response variables, a Spearman correlation analysis was applied.
Results: Myocardial collagen content quantified biochemically was significantly lower in FFC/SD compared to
FFC (P = 0.02). Furthermore, dietary normalization from a fat/fructose/cholesterol-rich diet to chow caused
stagnation of body weight and body fat percentage, normalized intravenous glucose tolerance index (KG) and
plasma lipid levels.
Conclusion: Dietary normalization led to lower LV collagen content in obese Göttingen Minipigs. Despite
gross obesity and significant deteriorations in glucose and lipid metabolism, only mild myocardial changes
were found in this model of obesity and therefore further model optimization is warranted in order to induce
more severe myocardial changes before dietary or pharmacological interventions.
Keywords: Dietary intervention, Obesity, Porcine model, Left ventricular remodeling, Collagen, Hydroxyproline,
Cardiomyocyte hypertrophy
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Background
Obesity is a steadily increasing health issue, and the world-
wide prevalence of obesity has nearly tripled between 1975
and 2016 [1]. This is a major concern because obesity is
associated with an increased risk of cardiovascular disease
[2, 3], including heart failure (HF) [2, 4]. Specifically, obes-
ity is associated with myocardial accumulation of
intra-myocellular lipids causing lipoapoptosis [5–7], left
ventricular (LV) hypertrophy [8, 9], and to some degree in-
creased myocardial fibrosis [10, 11]. These obesity-induced
myocardial alterations may contribute to impairment of
LV function [7, 12–15] and ultimately HF.
Dietary interventions accompanied by weight loss have
been shown to reduce both LV hypertrophy and myocar-
dial triglyceride content in obese humans [16–19]. Not
much is known about the impact of dietary change on
myocardial fibrosis in humans, but studies in obese ro-
dents have shown that weight loss obtained by calorie
restriction can attenuate myocardial fibrosis [20, 21]. Be-
sides weight loss and reversal of myocardial remodeling,
dietary interventions often reduce dyslipidemia and sys-
temic insulin resistance [16, 17, 19, 22]. Improvements
in insulin resistance without weight loss have been asso-
ciated with reversal of LV function abnormalities [22],
stating a possible primary effect of insulin resistance.
However, the underlying mechanisms of the attenuation of
myocardial remodeling are not yet fully understood. Trans-
lational animal models mimicking human obesity could fa-
cilitate more effective research in this field, enabling
investigations of the underlying mechanisms and providing
a better understanding of the related co-morbidities.
Over the past 30 years the use of porcine models in
cardiovascular research has grown [23]. Compared to ro-
dents, the pig is more similar to humans in terms of life-
span, anatomy, physiology, and metabolism [24]. More
importantly, when investigating obesity, the pig displays
many of the same metabolic abnormalities as humans
when fed excess calories [25–27]. Additionally, myocar-
dial fibrosis, fat infiltration and cardiac hypertrophy have
been described in different breeds of obese pigs [27–30].
Using a fat/fructose/cholesterol-rich diet-induced mini-
pig model of obesity, the aim of this study was to test the
hypotheses that dietary normalization from a fat/fructose/
cholesterol-rich diet to chow would 1) limit the develop-
ment of LV myocardial fibrosis, fat infiltration, and
hypertrophy and 2) improve plasma lipids and glucose me-
tabolism markers. Furthermore, we hypothesized that 3)
overall, the degree of obesity and level of plasma lipids and
glucose metabolism markers would be associated with
heart morphology.
Methods
This study is part of a large prospective intervention
study in Göttingen Minipigs investigating diet-induced
atherosclerosis and diabetes- and obesity-related abnor-
malities in the heart, liver and kidneys. Therefore some
of the presented groups and background characteristics
will also be published elsewhere in other contexts. The
study was approved by the Animal Experimental In-
spectorate, Ministry of Justice, Denmark.
Animals, experimental diets and feeding
Castrated male Göttingen Minipigs aged 6-7 months
(Ellegaard Göttingen Minipigs A/S, Dalmose, Denmark)
were housed at the Experimental Animal Unit at Univer-
sity of Copenhagen for the 13 months duration of study.
Animals were single-housed during periods with central
venous access (intravenous (IV) catheters) and otherwise
group-housed. Animals had free access to bedding mater-
ial and water, and were kept at a natural day/night cycle.
Overview of the study design and feeding paradigm
can be seen on Fig. 1. Study design was staggered with a
5-week interval between three cohorts of animals, and
all three study groups were represented in each cohort.
Animals were assigned to three different study groups; a
lean control group (SD, n = 8) fed standard minipig
chow that contained 2.8 kcal/g with (percentage by
weight) 13.0% protein, 2.1% fats and 52.4% carbohydrate
(Mini pig, Special Diet Services, Essex, United King-
dom); an obese group (FFC, n = 16) fed fat/fructose/cho-
lesterol-rich diet (9G4U and 5B4L, TestDiets®, Missouri,
USA) and a diet normalization group (FFC/SD, n = 16)
fed fat/fructose/cholesterol-rich diet for 7 months and
then changed to standard minipig chow for the remain-
der of the 13 months study period.
Two different diets with high fat, fructose and cholesterol
content were used in the study. 5B4L was used for the first
5 months of the study period [26], whereas, 9G4U was used
for the remainder of the study in order to avoid extremely
high plasma cholesterol. Both diets contained 4.1 kcal/g with
(percentage by weight) 16.7% protein, 19.8% fats and 42.3%
carbohydrate. The two fat/fructose/cholesterol-rich diets dif-
fered in fructose and cholesterol content, where 5B4L con-
tained (percentage by weight) 2% cholesterol and 17.8%
fructose and 9G4U 1% cholesterol and 18.8% fructose.
All animals were fed individually once daily. Animals re-
ceiving the fat/fructose/cholesterol-rich diet were fed 2%
of body weight (BW) with maximum 1000 g/day. How-
ever, 11 months after study initiation animals in FFC were
fed more restrictedly with a maximum of 500 g/day due
to severe obesity and lameness. Lean control animals were
fed according to the breeder’s recommendations (Fig. 1).
When animals in FFC/SD were changed to standard mini-
pig chow they were fed 500 g/day.
In vivo evaluations
In vivo evaluations included intravenous glucose toler-
ance test (IVGTT), blood sampling and a dual-energy
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x-ray absorptiometry (DEXA) scan and were all done in
overnight fasted animals (approx. 18 h). The evaluations
were performed in all three groups of pigs at two time
points, 1) mid-study, prior to diet adjustment for FFC/
SD and 2) before euthanasia.
An IVGTT was performed 3 to 7 weeks prior to diet
adjustment and euthanasia. The test was performed in
awake and unrestrained animals using pre-implanted IV
catheters in the jugular or cranial caval vein. After base-
line samples, an IV bolus of 0.3 g/kg glucose (500 g/L
glucose, SAD, Denmark) was given and blood was sam-
pled at 2, 5, 10, 15, 20, 30, 40, 50, 60 and 90 min after
the bolus. Blood was EDTA-stabilized and kept on wet
ice maximum 30 min before centrifugation at 2000×g
for 10 min at 4 °C. Plasma was stored at − 80 °C until
further analysis, except plasma used for glucose analysis
which was performed on the day of IVGTT. Intravenous
glucose tolerance index (KG) was calculated as the nega-
tive slope of the linear regression of the natural loga-
rithm to glucose vs. time from 5 to 30 min of IVGTT
and area under the curve for insulin response was calcu-
lated at sampling time 0–60 min (AUCInsulin), both as
previously described [26, 31]. Blood samples for evalu-
ation of plasma triglyceride and total cholesterol levels
were obtained 2-3 days prior to IVGTT, and handled as
described above.
Body weight was assessed on a weekly basis. One to
2 weeks prior to diet adjustment and euthanasia a
full-body scan using DEXA (GE Lunar Prodigy, GE
Healthcare, Brøndby, Denmark) was performed in anaes-
thetized animals to assess body fat percentage and lean
body mass (LBM). Relative heart weight was calculated
as the ratio of heart weight to LBM, and as the ratio of
heart weight to BW.
Plasma analyses
Plasma glucose was analyzed using Biosen auto analyzer
(BIOSEN, S_Line, EKF Diagnostics, Cardiff, United King-
dom) according to the manufacturer’s instructions. Plasma
samples were also analyzed for porcine insulin content using
Luminescent Oxygen Channeling Immunoassay as described
elsewhere [32] with few modifications regarding antibodies
(biotinylated mAb OXI005 was used instead of bioinylated
X14-6F34). Both triglyceride and total cholesterol concentra-
tions were analyzed using Cobas® 6000 auto analyzer (Roche,
Diagnostics Limited, Rotkreuz, Switzerland) according to the
manufacturer’s instruction. High-performance liquid chro-
matography using Superose 6 columns (10/300, GE Health-
care, Brøndby, DK) in an automatized system (Agilent 1100
HPLC system, Agilent Technologies, Waldbronn, GE) was
used to estimate group cholesterol fractions; high-density
lipoprotein cholesterol (HDL-C), low-density lipoprotein
cholesterol (LDL-C), very-low-density lipoprotein cholesterol
(VLDL-C). Pooled plasma samples from termination were
used and handled as previously described [26]. In short, two
Fig. 1 Overview of study design with focus on diet paradigm. Hatched study months indicate the two in vivo assessment periods: mid-study and
before termination. Approximate timing common for all three cohorts. 5B4L and 9G4U indicate the two different fat/fructose/cholesterol-rich diets
used. Nutrient profile differences between the two diets can be found in the text. SD = fed standard chow, FFC = fed fat/fructose/cholesterol-rich diet,
FFC/SD = dietary normalization
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to three animals with total plasma cholesterol concentrations
close to the group mean were selected (SD n= 2, FFC n= 3
and FFC/SD n= 3). Effort was made to select animals so that
each cohort was represented.
Euthanasia and tissue preparation
Animals were euthanized in surgical anesthesia by bleed-
ing from the axillae. Hereafter the heart was removed
from the animals and weighed. For biochemical analyses
2x2x11mm transmyocardial samples from LV free mid-
wall were snap-frozen in liquid nitrogen and stored at −
80 °C until use. Transmyocardial samples from LV free
midwall were also collected for histological analyses.
Samples were fixated in 4% neutral buffered formalde-
hyde for 28 h ± 5 h, dehydrated, and then embedded in
paraffin wax. Two tissue sections of 4 μm were either
stained with hematoxylin and eosin (H&E) or picro sir-
ius red (PSR) with Weigert’s iron hematoxylin nuclear
staining. All sections were digitalized using a NanoZoo-
mer XR (Hamamatsu Photonics, Japan) scanner. Sec-
tions with PSR staining were scanned at 20X and H&E
sections at 40X magnification.
Histological analyses
Semi-quantitative analysis of LV myocardial fat infiltration
and fibrosis
Degree of LV myocardial interstitial, epicardial and peri-
vascular fat infiltration was scored manually on digitalized
H&E stained sections using a scale 0/1+/2++/3+++, modi-
fied from van Hoeven & Factor [33]. In addition, the
degree of interstitial, replacement and perivascular fibrosis
was scored on PSR stained sections. Vessel average scores
of perivascular fat infiltration and perivascular fibrosis
were calculated for each animal. The observer was blinded
for group allocation in all histological analyses.
Quantitative analysis of LV myocardial collagen
Digital image analysis software Biotopix™ for Windows
7, version 7.0.0.2899 (Visiopharm®, Hørsholm, Denmark)
was used to quantify LV myocardial collagen fractions
on PSR stained sections. Algorithms were designed to
detect collagen and remaining myocardial tissue and cre-
ate regions of interest excluding epi- and endocardium.
Manual corrections were performed if needed. A colla-
gen fraction area was calculated.
Left ventricular cardiomyocyte size
Cardiomyocytes with a central nucleus and cross-sectioned
profile were selected, and the shortest diameter through
the nucleus was measured on H&E stained sections using
a software program (NDP.view2, Japan) (Fig. 2). An aver-
age diameter was calculated from 100 cardiomyocytes per
section.
Biochemical quantification of LV myocardial collagen
content
Using a commercially available hydroxyproline assay kit,
(Chondrex Inc., Redmond, WA, USA, CAT no.: 6017) LV
collagen content was quantified on transmural LV
snap-frozen samples. Before the assay, the LV samples
were freeze-dried at − 55 °C (Heto FD3, Heto-Holten A/S,
Allerød, Denmark) for 24 h, dry weight was determined
and the freeze-dried samples were crushed using mortar
and pestle. An acid hydrolysis was then performed using
200 μl 5 N hydrochloric acid per 10 mg wet weight cardiac
tissue, and samples were incubated at 99 °C for 36 h ac-
cording to Hanes and coworkers [34]. After incubation,
samples were cooled to room temperature and centrifuged
for 3 min at 9000×g. Supernatant was collected and the
hydroxyproline assay was performed according to manu-
facturer’s instructions. All standards, samples and sample
blanks were run in duplicate and rerun if coefficient of
variance (CV) was more than 15%.
Biochemical quantification of LV myocardial triglyceride
content
LV transmural snap-frozen samples were kept cold on
dry ice and crushed using mortar and pestle. Around
100 mg crushed LV tissue was mixed with 2 mL 0.15 M
sodium acetate with triton-X100 (0.75%) to solubilize tis-
sue lipids. Samples were then homogenized for 30 s with
T25 digital Ultra Turrax® (IKA, Staufen, Germany) at
20000 repetitions per minute and immediately placed in
a 90–100 °C water bath for 2 min and 15 s. After cooling
down on wet ice, the samples were centrifuged at
3400×g for 10 min and supernatant was collected. Tri-
glyceride analysis was performed using Cobas® 6000 auto
analyzer according to manufacturer’s instructions and
adjusted to tissue weight. All samples were run in dupli-
cate and rerun if CV was more than 15%.
Statistical analysis
Group differences between continuous variables were
evaluated using a Kruskal-Wallis test with Wilcoxon
Rank-sum post hoc test. ANOVA was not used due to
lack of homogeneity of the residuals even after trans-
formation. Fisher’s exact test was performed on categor-
ical variables (epicardial fat, interstitial fat and interstitial
fibrosis) to determine group differences.
To test for correlations between myocardial changes
and body composition measurements (BW, body fat per-
centage, LBM), heart weight, circulating lipids (triglycer-
ide, total cholesterol) and glucose metabolism markers
(KG and AUCInsulin) a Pearson correlation analysis was
performed. A Shapiro-Wilk test was used to test for nor-
mality of response variable and if normality was not ob-
tained, a non-parametrical Spearman correlation analysis
was performed.
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Data and results are presented as median and inter-
quartile range (25th–75th). Statistical analyses were
made using statistical software (SAS® 9.4, SAS Institute
Inc., Cary, NC, USA). Graphical illustrations and calcu-
lation of KG and AUCInsulin were made using GraphPad
Prism® (7.0c for Macintosh, GraphPad Software Inc., San
Diego, CA, USA). A value of P < 0.05 was considered sig-
nificant for the analyses.
Results
Five out of forty animals did not complete the study. Four
of these animals were euthanized before time; one due to
lameness (FFC/SD n = 1); another due to spontaneous
acute bleeding (FFC/SD n = 1) (diagnosed trombocytopenia
purpura, a known background finding in Göttingen Mini-
pigs [35]); and two (SD n = 1, FFC n = 1) as a result of pro-
cedure related complications. The last animal (FFC n = 1)
died suddenly after a short period with acute respiratory
distress, probably caused by circulatory failure.
Body composition and heart weight
As depicted in Fig. 3, BW of FFC/SD stagnated compared
to the remaining groups after dietary normalization. Body
composition, absolute and relative heart weight data are
presented in Table 1. Body weight, body fat percentage
and LBM were significantly higher in FFC and FFC/SD
compared to SD animals mid-study. No differences were
observed between FFC and FFC/SD at this time point. At
Fig. 2 Example of cardiomyocyte diameter measurements. Measurement of the shortest diameter through the nucleus of cross-sectioned
cardiomyocytes on hematoxylin and eosin stained sections (left corner bar is 50 μm). Example of FFC group animal
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Fig. 3 Body weight development throughout the study period for all three groups. All animals were weighed weekly. Arrow: Time point where
FFC/SD animals were changed from a fat, fructose and cholesterol-rich diet (FFC) to standard minipig chow, which was approximately 8 months
after study initiation. SD = fed standard chow, FFC/SD = dietary normalization
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study termination BW and body fat percentage were
significantly higher in FFC and FFC/SD compared to SD
animals, and these body composition measurements were
significantly lower in FFC/SD compared to FFC. No differ-
ence in LBM was observed between groups at the end of
study.
Heart weight was significantly higher in both FFC and
FFC/SD compared to SD animals. Despite no statistical
significant difference in heart weight between FFC and
FFC/SD, a tendency towards a lower heart weight was no-
ticed in FFC/SD (P = 0.06). Heart weight normalized for
BW was significantly lower in FFC compared to both SD
and FFC/SD. Furthermore, heart weight normalized for
LBM was significantly higher in FFC and FFC/SD com-
pared to SD animals and animals in FFC/SD had a signifi-
cantly lower normalized heart weight compared to FFC.
Circulating lipids and glucose metabolism markers
Circulating lipids and glucose metabolism markers are
presented in Table 2. Mid-study, plasma triglyceride
levels were significantly increased in FFC compared to
SD animals, but no difference was observed between an-
imals in FFC/SD and the two other groups. Animals in
both FFC/SD and FFC had significantly increased total
cholesterol levels compared to SD animals mid-study. At
termination, plasma triglyceride and total cholesterol
levels in FFC were significantly increased compared to
animals in the two other groups. Furthermore, no differ-
ences in triglyceride or total cholesterol levels were ob-
served between FFC/SD and SD animals at termination.
Mid-study, KG was significantly decreased in FFC and
FFC/SD compared to SD animals suggesting altered glu-
cose metabolism in the two groups. At termination, KG in
FFC was significantly decreased compared to the two
other groups, whereas no difference between FFC/SD and
SD was observed. No differences in fasting glucose levels
or AUCInsulin were observed between any of the groups at
the two time points. The HPLC results of the pooled sam-
ples showed that the SD (HDL-C / LDL-C / VLDL-C:
48.06% / 50.70% / 1.24%) and FFC/SD (HDL-C / LDL-C /
VLDL-C: 41.50% / 56.79% / 1.71%) groups had cholesterol
fractions distributed predominantly in HDL and LDL,
whereas the FFC group (HDL-C / LDL-C / VLDL-C:
13.12% / 47.74% / 39.14%) predominantly had cholesterol
fractions distributed into LDL and VLDL. Though, data is
not conclusive, a fat/fructose/cholesterol-rich diet feeding
appeared to increase amount of LDL-C and VLDL-C,
while diet normalization returned the cholesterol fractions
to an almost normal distribution.
Left ventricular fibrosis
Animals in FFC/SD had significantly lower LV myocardial
collagen content compared to FFC when collagen content
was assessed biochemically (P = 0.02). However, no differ-
ence between SD and FFC or FFC/SD was observed using
this method (Fig. 4a). Quantification of collagen by
image-analysis revealed no difference between groups
(Fig. 4b), and further no significant difference in interstitial
or perivascular fibrosis score was found between groups
when evaluated semi-quantitative (Fig. 4c, d). However, a
Table 1 Body composition, absolute and relative heart weight
SD n = 7 FFC n = 14 FFC/SD n = 14 Overall P value
BW (kg)
Mid-study 31.0 (30.0–32.0) 50.0 (47.0–55.0)*** 49.5 (47.0–54.0)*** 0.0003
Termination 39.0 (38.0–41.0) 78.0 (69.0–81.0)*** 55.0 (51.0–59.0)***†††† <.0001
Fat percentage (%)
Mid-study 20.5 (18.5–26.3) 40.2 (37.6–41.9)*** 41.6 (38.8–44.5)*** 0.0001
Termination 27.6 (24.0–30.7) 64.2 (61.4–67.6)*** 47.3 (41.2–50.2)***†††† <.0001
LBM (kg)
Mid-study 22.8 (20.1–23.1) 27.1 (25.0–28.2)** 25.6 (24.4–26.3)** 0.002
Termination 26.9 (24.0–28.6) 27.0 (24.8–27.8) 29.5 (27.3–30.5) 0.2
HW (g)
Termination 131 (115–142) 199 (181–208)a*** 173 (168–180)*** <.0001
HW/BW (g/kg)
Termination 3.3 (3.1–3.4) 2.6 (2.5–2.8)a*** 3.3 (3.0–3.4)†††† <.0001
HW/LBM (g/kg)
Termination 5.0 (4.2–5.2) 7.7 (6.8–8.2)a*** 6.2 (5.9–6.7)***††† <.0001
Data is presented as median and interquartile range (25th–75th)
SD fed standard chow, FFC fed fat/fructose/cholesterol-rich diet, FFC/SD dietary normalization, BW body weight, LBM lean body mass, HW heart weight
**P < 0.01; ***P < 0.001, significantly different from SD, †††P < 0.001; ††††P < 0.0001, significantly different from FFC
a n = 13
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trend towards a difference in perivascular fibrosis between
groups was noticed (P = 0.06, Fig. 4d). No signs of replace-
ment fibrosis were found in any of the groups.
Left ventricular fat
Epicardial fat score differed between groups (P =
0.02). Higher scores were given to FFC animals com-
pared to SD (P = 0.01), but no difference was found be-
tween FFC and FFC/SD, or FFC/SD and SD (Fig. 5a).
However, no significant difference in interstitial or peri-
vascular fat infiltration score was observed between
groups (Fig. 5b, c). There was no difference in LV trigly-
ceride content between groups when assessed biochem-
ically (Fig. 5d).
Cardiomyocyte hypertrophy
Cardiomyocyte diameter was significantly increased in
FFC (P = 0.005) and FFC/SD (P = 0.04) compared to SD
animals. Although not reaching statistical significance
(P = 0.09), a trend towards lower cardiomyocyte diam-
eter was observed in FFC/SD compared to FFC (Fig. 6).
Correlation analyses
All correlation analyses can be seen in Table 3.
Cardiomyocyte diameter was positively correlated with
BW (r = 0.54, P = 0.0008), body fat percentage (r = 0.53,
P = 0.001), and heart weight (r = 0.51, P = 0.002). LV trigly-
ceride content assessed biochemically was also positively
correlated with BW (rs = 0.45, P = 0.007), body fat percent-
age (rs = 0.35, P = 0.04), heart weight (rs = 0.35, P = 0.04),
and plasma triglyceride level (rs = 0.37, P = 0.03). LV myo-
cardial collagen content assessed biochemically tended to
be positively correlated with body fat percentage (rs = 0.32,
P = 0.06), plasma total cholesterol level (rs = 0.31, P =
0.08), plasma triglyceride level (rs = 0.30, P = 0.08) and
further LV myocardial collagen content tended to be in-
versely correlated with KG (rs = − 0.35, P = 0.06) and LBM
(rs = − 0.29, P = 0.09). Collagen level quantified by
image-analysis tended to be positively correlated with
BW (r = 0.29, P = 0.09), body fat percentage (r = 0.29, P =
0.09) and plasma total cholesterol level (r = 0.32, P = 0.07).
Remaining correlations were not significant.
Discussion
The main finding of the present study is that a dietary
change from a fat/fructose/cholesterol-rich diet to stand-
ard minipig chow limited the amount of collagen in the
myocardium of obese Göttingen Minipigs. However,
dietary normalization did not have a significant benefi-
cial effect on any of the other LV myocardial parameters
Table 2 Circulating lipids and glucose metabolism markers
SD n = 7 FFC n = 14 FFC/SD n = 14 Overall P value
Triglyceride (mM)
Mid-study 0.38 (0.29–0.41) 0.57 (0.37–0.76)* 0.48 (0.33–0.52) 0.04
Termination 0.34 (0.29–0.35)b 0.63 (0.54–0.88)h** 0.36 (0.32–0.45)g††† <.0001
Total cholesterol (mM)
Mid-study 2.0 (1.6–2.2) 14.1 (11.1–22.1)*** 14.6 (11.2–18.7)*** 0.0003
Termination 1.7 (1.6–2.2)b 11.9 (11.0–13.2)h*** 1.9 (1.6–2.0)g†††† <.0001
Glucose (mM)
Mid-study 3.8 (3.5–4.0) 4.0 (3.9–4.2)h 3.9 (3.6–4.2)f 0.3
Termination 3.4 (3.2–3.6)b 3.7 (3.6–3.9) 3.8 (3.7–4.0)e 0.05
KG (min
−1)
Mid-study 3.1 (2.8–4.9) 2.2 (1.9–2.4)h** 2.1 (1.9–2.1)** 0.005
Termination 3.2 (2.7–3.5)b 2.1 (1.8–2.4)h** 3.2 (2.5–3.6)† 0.01
AUCInsulin (pM*min)
Mid-study 6983 (6344–12,602) 10,519 (9780–16,901)h 11,834 (10996–14,716)d 0.2
Termination 12,573 (11507–20,683)a 27,168 (17204–35,562)h 24,032 (20478–28,147)c 0.07
Data is presented as median and interquartile range (25th–75th)
SD fed standard chow, FFC fed fat/fructose/cholesterol-rich diet, FFC/SD dietary normalization, KG intravenous glucose tolerance index, AUCInsulin area under the
curve of insulin
*P < 0.05; **P < 0.01; ***P < 0.001, significantly different from SD, †P < 0.05; †††P < 0.001; ††††P < 0.0001, significantly different from FFC
a n = 5
b n = 6
c n = 8
d n = 9
e n = 10
f n = 11
g n = 12
h n = 13
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investigated. In terms of other general health benefits of
dietary normalization, BW gain was reduced, dyslipid-
emia was reversed and intravenous glucose tolerance
index was improved.
Using a biochemical assessment of collagen, animals in
FC/SD had significantly lower myocardial collagen con-
tent compared to FFC at termination. To date, no pre-
vious porcine studies investigating the effect of dietary
normalization on reversal of myocardial pathological alter-
ation have been reported. However, previous studies in
obese rodents have explained the attenuation of myocar-
dial fibrosis after a dietary intervention by a reduction in
myocardial oxidative stress and inflammation [20, 21].
This is in line with porcine studies linking increased myo-
cardial oxidative stress, inflammation and development of
myocardial fibrosis [27, 30]. In a previous study of obese
Göttingen Minipigs levels of oxidized low-density lipopro-
tein (oxLDL) and C-reactive protein, markers of systemic
inflammation, were found to be increased after 22 weeks
of a fat, fructose and cholesterol-rich diet [26]. Dietary
fructose has been shown to contribute to inflammation in
different tissues [36] and the dietary content of fructose in
the present study may therefore have caused inflammation
similar to the study by Ludvigsen and coworkers [26].
Furthermore, increased levels of oxLDL have been directly
associated with stimulation of cardiac fibroblast signaling
and collagen formation [37]. Regarding oxidative stress in
the state of obesity, it has been proposed that hypergly-
cemia and insulin resistance may increase myocardial oxi-
dative stress as a result of increased lipid metabolism [38].
In agreement with this, we found a tendency to an inverse
correlation between LV myocardial collagen content and
KG in the present study. Moreover, a study by Kosmala
and coworkers [39] showed that normal body mass index
but increased body fat content was associated with a profi-
brotic state, indicating that adiposity may stimulate fibro-
sis formation. This is supported by the trend towards a
positive correlation between LV collagen content and body
fat percentage observed in the present study. A reduction
in systemic oxidative stress and inflammatory markers
was induced by 28-days of calorie restriction in overweight
and obese women [40], suggesting that the timeframe of
the present study might be sufficient to lower these
parameters.
a b
c d
Fig. 4 Left ventricular fibrosis. Left ventricular a collagen content quantified biochemically, b collagen area fraction assessed by digital image
software and c interstitial and d perivascular fibrosis scores evaluated on histological sections stained with picro sirius red with Weigert’s iron
hematoxylin nuclear staining. SD = fed standard chow, FFC = fed fat/fructose/cholesterol-rich diet, FFC/SD = dietary normalization. Black bars
represent median and interquartile range (25th–75th). * = P < 0.05
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Studies of obese humans have shown that weight loss
and maintenance of weight loss is important for im-
provements in LV geometry [16, 22], probably because
the increase in body size is a driving factor for the
hypertrophic pattern observed in obese subjects [41],
due to pressure and volume overload associated with in-
creasing body size [42]. In the present study, no signifi-
cant difference in cardiomyocyte diameter or heart
weight was observed between FFC and FFC/SD, even
though BW was markedly lower in animals in FFC/SD.
Autopsy studies of obese humans suggest increase of
heart weight until a certain BW threshold, after which
only modest heart weight changes are observed [9, 41,
43]. The lower heart weight/BW ratio observed in FFC
compared to both SD and FFC/SD may suggest that
such a threshold also exist in pigs where animals in FFC
may have reached the BW threshold. This relation could
also explain why the differences in heart weight and car-
diomyocyte diameter between FFC and FC/SD were less
pronounced and did not reach statistical significance in
contrast body composition measurements. Heart weight
was further normalized for LBM to quantify the degree
of cardiac hypertrophy [9] and this revealed a significant
difference between FFC and FFC/SD with animals in
FFC having the largest ratio. Together with the heart
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Fig. 5 Left ventricular fat. Left ventricular a epicardial, b interstitial, c perivascular fat infiltration scores evaluated on hematoxylin and eosin stained
sections and d left ventricular triglyceride content quantified biochemically. SD = fed standard chow, FFC = fed fat/fructose/cholesterol-rich diet, FFC/
SD = dietary normalization. Black bars represent median and interquartile range (25th–75th). * = P < 0.05
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Fig. 6 Left ventricular cardiomyocyte diameter. Left ventricular
cardiomyocyte diameter assessed on hematoxylin and eosin stained
sections. SD = fed standard chow, FFC = fed fat/fructose/cholesterol-
rich diet, FFC/SD = dietary normalization. Black bars in graph represent
median and interquartile range (25th–75th). * = P < 0.05, ** = P < 0.01
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weight/BW ratio, this may suggest that dietary
normalization stopped the progression of cardiac hyper-
trophy. Correlation analyses also revealed positive correla-
tions between obesity (BW and body fat percentage) and
cardiomyocyte diameter, stating the importance of body size
as a mediator of LV hypertrophy, also in the present study.
A positive correlation between cardiomyocyte diameter
and heart weight was found in the current study, showing
that cardiomyocyte hypertrophy is an important compo-
nent of increase in cardiac weight. However, it is worth
noticing that increased heart weight also can be caused by
increased epicardial fat mass or myocardial fat infiltration
[44, 45], which is supported by the positive correlation
found between heart weight and LV triglyceride content.
Furthermore, epicardial fat score assessed histologically
was significantly higher in both FFC and FFC/SD
compared to SD and this may also have contributed to the
larger heart weight observed in these two groups.
A limitation of the present study was that no myocardial
tissue was collected mid-study, prior to diet adjustment
for FFC/SD and therefore it is difficult to determine if the
dietary normalization reversed or just stopped the pro-
gression of the myocardial alterations. Tissue collection at
this time and/or relevant in vivo assessments would there-
fore have been preferred. A transmural sample of LV was
used for the biochemical assessment of collagen whereas
the epi- and endocardium were not a part of the histo-
logical fibrosis analyses. An increase in epi- and/or endo-
cardial collagen in FFC may therefore have influenced that
a significant difference in collagen content only was ob-
served when collagen was assessed biochemically. Com-
pared to previous porcine studies [27, 30] only minor
myocardial pathological alterations were induced in FFC
despite 13 months of fat/fructose/cholesterol-rich diet.
The reason might be difference between porcine breeds or
differences in study setup e.g. castration. All animals were
castrated before study initiation because castrated male
Göttingen Minipigs become more prone to obesity and
metabolic changes after castration [31]. Literature state
that castration may protect against age-related myocardial
fibrosis in mice [46], but also that castration promotes
myocardial fibrosis formation in rodent heart failure
models [47, 48]. However, to the authors’ knowledge, no
studies have investigated this relationship in pigs. The lack
of myocardial changes in the present study poses a limita-
tion to the study and it could be speculated that more pro-
nounced effects of dietary normalization would have been
observed if more severe myocardial alterations had been
induced.
Conclusion and perspectives
Dietary change from a fat/fructose/cholesterol-rich diet
to standard minipig chow limited the development of
myocardial collagen content in obese Göttingen Mini-
pigs compared to animals staying on the fat/fructose/
cholesterol-rich diet for further 6 months. In addition,
the degree of adiposity and glucose tolerance might have
influenced myocardial collagen level. Plasma triglyceride
and total cholesterol levels also improved after dietary
normalization, however, plasma lipid levels did not cor-
relate with myocardial collagen content. Only mild myo-
cardial changes were found in this model of obesity and
it is therefore important that future studies focus on in-
ducing more severe myocardial changes before dietary
or pharmacological interventions.
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